Ciphix Expands European Leadership with Acquisition of Bizzomate

Ciphix, a Rotterdam-based hyperautomation specialist, has solidified its position as a key player in Europe’s tech landscape with the acquisition of Bizzomate, a leading provider of low-code software solutions based in Limburg. This strategic move underscores Ciphix’s ambition to lead the hyperautomation sector across the continent. Koen Mallee, CEO of Ciphix, highlighted the significance of…

Read More

Create Wellness Secures $5 Million in Series A Funding to Propel Expansion of Creatine-Based Innovations

Create Wellness, Inc., a trailblazer in the health and wellness sector, has successfully raised $5 million in Series A funding, spearheaded by Unilever Ventures. This latest investment boosts Create Wellness’ total funding to $7.3 million. The funds will be instrumental in advancing the company’s mission to broaden access to its pioneering creatine-based products. Founded by…

Read More

Donna Raises €1.6 Million to Revolutionize Sales with AI Assistant

Ghent-based AI startup Donna secures €1.6 million in pre-seed funding from prominent US and European investors, including Pitchdrive, Everywhere Ventures, Fortino, Syndicate One, and WeLoveFounders, alongside notable angel investors. This investment aims to bolster Donna’s team expansion and accelerate its ambitious rollout across Europe and the United States. Founded by seasoned entrepreneurs Nicolas Christiaen and…

Read More

Faye Secures $31 Million in Series B Funding to Revolutionize Travel Protection

Faye, the acclaimed travel platform known for integrating insurance, assistance, and financial solutions, has successfully raised $31 million in Series B funding. This latest round elevates Faye’s total funding to $49 million. The investment was spearheaded by Portage, with notable contributions from Lumir Ventures and continued support from existing backers F2 Venture Capital, Viola Ventures,…

Read More

Innovating the Future of Tech: Revolka Co., Ltd. Pioneers New Solutions in AI and Robotics

RevolKa Ltd. a pioneering biotech firm at the forefront of AI-driven protein engineering, proudly announces the successful closure of its Series A extension funding, raising a total of 250 million JPY (approximately US$1.7 million). This latest infusion of capital, which includes a 100 million JPY (US$0.7 million) financing round, is poised to significantly enhance RevolKa’s…

Read More

Movate Appoints Dariyus Setna as EVP and Chief Revenue Officer for Digital Services

Movate, a leading digital technology and customer experience (CX) services provider, has named Dariyus Setna as its new Executive Vice President (EVP) and Chief Revenue Officer (CRO) for Digital Services. Setna, a seasoned business leader with over 25 years of experience, joins Movate from Globant, where he significantly contributed to quadrupling revenue and increasing market…

Read More

Soluna Cloud Secures $13.75 Million to Power Sustainable AI Solutions

Soluna Holdings, Inc. (NASDAQ: SLNH), a trailblazer in green data centers for intensive computing applications, has announced a significant funding boost for its subsidiary, Soluna Cloud. The additional $1.25 million in financing, facilitated by BitOoda Technologies and Imperial Capital, brings Soluna Cloud’s total credit facility to $13.75 million. This capital injection is earmarked to propel…

Read More

Juno Secures $8.5 Million to Expand Child Disability Insurance for Working Parents

Juno, a trailblazer in the realm of child disability insurance in the U.S., has announced a significant milestone with the closure of an $8.5 million Series A funding round led by Spero Ventures, alongside contributions from Floating Point, Newark Ventures, and WVV Capital. This latest infusion of capital brings Juno’s total raised funds to $12.5…

Read More
Stacey Pugh, CEO of Endogenex

Endogenex Secures $88 Million in Series C Funding to Advance Breakthrough Diabetes Treatment

Endogenex, a pioneering clinical-stage medical device company dedicated to transforming diabetes care, has successfully closed an oversubscribed Series C financing round, raising a remarkable $88 million. This substantial funding boost will propel the company towards completing its pivotal ReCET Clinical Study, a critical step in bringing their innovative ReCET™ System to market for patients suffering…

Read More